117 related articles for article (PubMed ID: 945228)
1. Plasma prolactin and its relationship to risk factors in human breast cancer.
Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY
Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228
[TBL] [Abstract][Full Text] [Related]
2. The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom).
De Stavola BL; Wang DY; Allen DS; Giaconi J; Fentiman IS; Reed MJ; Bulbrook RD; Hayward JL
Cancer Causes Control; 1993 Jul; 4(4):331-40. PubMed ID: 8347782
[TBL] [Abstract][Full Text] [Related]
3. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Chaudary M; Hayward JL
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1541-8. PubMed ID: 3678318
[TBL] [Abstract][Full Text] [Related]
4. Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk.
Sherman B; Wallace R; Bean J; Schlabaugh L
J Clin Endocrinol Metab; 1981 Mar; 52(3):488-93. PubMed ID: 7462400
[TBL] [Abstract][Full Text] [Related]
5. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.
Kwa HG; Wang DY
Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758
[TBL] [Abstract][Full Text] [Related]
6. Migraine and reporoductive hormones throughout the menstrual cycle.
Epstein MT; Hockaday JM; Hockaday TD
Lancet; 1975 Mar; 1(7906):543-8. PubMed ID: 47017
[TBL] [Abstract][Full Text] [Related]
7. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Hayward JL; Gravelle IH
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1225-31. PubMed ID: 3416905
[TBL] [Abstract][Full Text] [Related]
8. Relationship of blood prolactin levels and the risk of subsequent breast cancer.
Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR
Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
Kampert JB; Whittemore AS; Paffenbarger RS
Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
11. Characteristics that predict risk of breast cancer before and after the menopause.
Paffenbarger RS; Kampert JB; Chang HG
Am J Epidemiol; 1980 Aug; 112(2):258-68. PubMed ID: 7416152
[TBL] [Abstract][Full Text] [Related]
12. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
[TBL] [Abstract][Full Text] [Related]
13. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
[TBL] [Abstract][Full Text] [Related]
14. Menstrual cycle patterns and breast cancer risk factors.
Wallace RB; Sherman BM; Bean JA; Leeper JP; Treloar AE
Cancer Res; 1978 Nov; 38(11 Pt 2):4021-4. PubMed ID: 698949
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
[TBL] [Abstract][Full Text] [Related]
16. Prolactin levels in populations at risk for breast cancer.
Hill P; Wynder EL; Kumar H; Helman P; Rona G; Kuno K
Cancer Res; 1976 Nov; 36(11 Pt 1):4102-6. PubMed ID: 975051
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in adiposity-related genes are associated with age at menarche and menopause in breast cancer patients and healthy women.
Kim KZ; Shin A; Lee YS; Kim SY; Kim Y; Lee ES
Hum Reprod; 2012 Jul; 27(7):2193-200. PubMed ID: 22537818
[TBL] [Abstract][Full Text] [Related]
18. The impact of the Occupation of Guernsey 1940-1945 on breast cancer risk factors and incidence.
Fentiman IS; Allen DS; Ellison GT
Int J Clin Pract; 2007 Jun; 61(6):937-43. PubMed ID: 17504356
[TBL] [Abstract][Full Text] [Related]
19. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
de Waard F; Kwa HG; Poortman J
Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
[TBL] [Abstract][Full Text] [Related]
20. Menstrual factors and breast cancer risk.
Kvåle G; Heuch I
Cancer; 1988 Oct; 62(8):1625-31. PubMed ID: 3167776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
